TRAX insider transaction filings
First Tracks Biotherapeutics, Inc. — 41 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-17. Screen TRAX transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 8 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 39,265 shares, $1,758,145 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 39,265 shares @ $44.78 ($1,758,145) by Ware J. Anthony, filed 2026-09-04.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Ware J. Anthony — Director | 1 | — | 1 leg · 39,265 sh · $1,758,145 | 3 |
| Faga Daniel — President, CEO, Director | 2 | — | — | 2 |
| Lizzul Paul F. — Chief Medical Officer | 2 | — | — | 2 |
| Orwin John A — Director | 1 | — | — | 2 |
| STONE BENJAMIN — Chief Business Officer | 2 | — | — | 2 |
Recent Form 4 filings — First Tracks Biotherapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Orwin John A — Director | Option exercise (M): 1,300 @ $0 · Option exercise (M): 1,300 (derivative) @ $0 | EDGAR |
| 2026-09-04 | 4 | Ware J. Anthony — Director | Option exercise (M): 39,265 @ $5.74 · Sale (S): 39,265 @ $44.78 · Option exercise (M): 28,571 (derivative) @ $0 · Option exercise (M): 10,694 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Faga Daniel — President, CEO, Director | Grant/award (A): 193,575 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Lizzul Paul F. — Chief Medical Officer | Grant/award (A): 60,492 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | STONE BENJAMIN — Chief Business Officer | Grant/award (A): 60,492 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | STONE BENJAMIN — Chief Business Officer | Grant/award (A): 60,492 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Faga Daniel — President, CEO, Director | Grant/award (A): 193,576 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Lizzul Paul F. — Chief Medical Officer | Grant/award (A): 60,492 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Ware J. Anthony — Director | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Jain Rita — Director | Option exercise (M): 7,330 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 · Option exercise (M): 1,300 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Marquet Magda — Director | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Schmid John P. — Director | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Orwin John A — Director | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | FENTON DENNIS M — Director | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | Ware J. Anthony — Director | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | Jain Rita — Director | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | Marquet Magda — Director | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | Schmid John P. — Director | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | Orwin John A — Director | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | FENTON DENNIS M — Director | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | STONE BENJAMIN — Chief Business Officer | Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 72,300 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Tamboli Ajim — Chief Financial Officer | Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 13,600 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Ware J. Anthony — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Lizzul Paul F. — Chief Medical Officer | Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 72,300 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Jain Rita — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Faga Daniel — President, CEO, Director | Grant/award (A): 100,200 (derivative) @ $0 · Grant/award (A): 271,100 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Marquet Magda — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Schmid John P. — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Orwin John A — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | FENTON DENNIS M — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Tamboli Ajim — Chief Financial Officer | Grant/award (A): 45,700 (derivative) @ $0 · Grant/award (A): 41,233 (derivative) @ $0 · Grant/award (A): 41,233 (derivative) @ $0 · Grant/award (A): 41,234 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Ware J. Anthony — Director | Grant/award (A): 28,571 (derivative) @ $0 · Grant/award (A): 10,694 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · +7 more | EDGAR |
| 2026-04-22 | 4 | Lizzul Paul F. — Chief Medical Officer | Grant/award (A): 83,500 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 67,070 (derivative) @ $0 · Grant/award (A): 115,540 (derivative) @ $0 · Grant/award (A): 97,200 (derivative) @ $0 · +5 more | EDGAR |
| 2026-04-22 | 4 | Jain Rita — Director | Grant/award (A): 10,600 (derivative) @ $0 · Grant/award (A): 8,015 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 1,300 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-22 | 4 | Faga Daniel — President, CEO, Director | Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 2,321 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 · Grant/award (A): 194,900 (derivative) @ $0 · Grant/award (A): 379,620 (derivative) @ $0 · Grant/award (A): 305,500 (derivative) @ $0 · +5 more | EDGAR |
| 2026-04-22 | 4 | Marquet Magda — Director | Grant/award (A): 784 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 · Grant/award (A): 10,600 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · +3 more | EDGAR |
| 2026-04-22 | 4 | EcoR1 Capital, LLC — 10% owner | Sale (S): 4,705,575 @ $13.81 | EDGAR |
| 2026-04-22 | 4 | Schmid John P. — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 · +6 more | EDGAR |
| 2026-04-22 | 4 | Orwin John A — Director | Grant/award (A): 3,311 (derivative) @ $0 · Grant/award (A): 10,600 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 8,250 (derivative) @ $0 · Grant/award (A): 1,300 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-22 | 4 | ANAPTYSBIO, INC — 10% owner | Other (J): 100 | EDGAR |
| 2026-04-22 | 4 | FENTON DENNIS M — Director | Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 5,507 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 · +6 more | EDGAR |
Recent 8-K events — First Tracks Biotherapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TRAX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →